Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

about

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

Item

http://www.wikidata.org/entity/Q42039578

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@en

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@nl

type

Item

label

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@en

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@nl

prefLabel

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@en

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@nl

P1476

Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report.

@en

P2093

Anna Lisa Fassari

http://www.w3.org/2001/XMLSchema#string

Concetta Romano

http://www.w3.org/2001/XMLSchema#string

Consuelo Tamburella

http://www.w3.org/2001/XMLSchema#string

Marco Bertini

http://www.w3.org/2001/XMLSchema#string

Marco Messina

http://www.w3.org/2001/XMLSchema#string

Martino Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Nephropathy in type 2 diabetes.

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

Nephropathy in patients with type 2 diabetes mellitus.

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

Aminaftone, a derivative of 4-aminobenzoic acid, downregulates endothelin-1 production in ECV304 Cells: an in vitro Study.

Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark.

Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy.

Microalbuminuria in patients with NIDDM: an overview.

Evolution, risk factors, and prognostic implications of albuminuria in NIDDM.

Effects of aminaftone 75 mg TID on soluble adhesion molecules: a 12-week, randomized, open-label pilot study in patients with systemic sclerosis.

P2888

1752-1947-8-443

P304

443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/1752-1947-8-443

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269768412

http://www.w3.org/2001/XMLSchema#string

P6179

1014005130

http://www.w3.org/2001/XMLSchema#string

P698

25524258

http://www.w3.org/2001/XMLSchema#string

P932

4320529

http://www.w3.org/2001/XMLSchema#string